http://web.archive.org/web/20140208143704id_/http://www.cnn.com:80/2009/HEALTH/07/31/tamiflu.side.effects/

@entity1 , @entity0 -- more than half of children taking antiviral drug @entity7 suffer side - effects such as nausea , insomnia and nightmares , @entity4 researchers have said			1
anti-viral drug @entity7 caused nausea , insomnia and nightmares among some children studies show			1
two studies from experts at the @entity18 ( @entity18 ) showed a " high proportion " of @entity4 schoolchildren reporting problems after taking the anti-viral drug			0
@entity22 was collected from children at three schools in @entity1 and one in south west @entity0 who were given @entity7 earlier this year after classmates became infected			2
the studies by @entity18 experts were carried out in the early stages of the epidemic between april and may , when everyone sharing a classroom with a child who developed swine flu was given the drug , even if they showed no symptoms			0
their research , published in the @entity40 scientific journal , looked at side - effects reported by 11 and 12 - year - old pupils in one school year in a secondary school in south west @entity0			1
a total of 248 pupils took part in the study ; their school was closed for 10 days after a pupil there contracted swine flu during a holiday in @entity54 , researchers said			2
seventy - seven percent of these children took the full course of @entity7 , according to researchers			1
the report said : " fifty - one percent experienced symptoms such as feeling sick ( 31.2 percent ) , headaches ( 24.3 percent ) and stomach ache ( 21.1 percent )			0
" one of the studies found that evidence of side - effects prompted @entity4 ministers to change the policy so only confirmed or suspected cases were prescribed @entity7			1
the second study , also published by @entity40 , looked at 103 children			0
the research found that 53 percent of children at three @entity1 schools had one or more side effects			2
the most common side effect was nausea , with 29 percent of the pupils complaining of this			2
another 20 percent of those questioned by researchers complained of stomach pain or cramps , while 12 percent had problems sleeping , the study found			0
almost one in five ( 18 percent ) of the children reported a " neuropsychiatric side effect , " such as poor concentration , inability to think clearly , problems sleeping , feeling dazed or confused , bad dreams or nightmares and " behaving strangely , " researchers said			1
the @entity4 's @entity91 said in a statement : " the @entity94 regulatory position remains that no causal association between @entity7 ( or @entity96 ) and an increase in neuropsychiatric events has been established			0
" reports from @entity100 , where @entity7 has in the past been widely - used against seasonal flu , has linked the drug in rare instances with unusual neurological and psychiatric disturbances in children , according to media reports			1
@entity100 is now advising against prescribing @entity7 to youngsters aged 10 to 19 after its own studies revealed people reporting psychiatric symptoms , according to media reports			1
a spokeswoman for pharmaceutical company @entity115 , which manufactures @entity7 , told @entity2 : " abnormal behavior is recognized to occur in patients with influenza virus infection including those taking and not taking antiviral drugs			0
" following extensive investigations , no mechanism has been identified by which @entity7 could contribute to such events			0
following a review by an @entity129 advisory committee in the @entity130 , the labels for both @entity96 ( zanamivir ) and @entity7 have been updated to inform physicians that influenza can be associated with a variety of neurologic and behavioural symptoms			0

researchers say more than half of children who took @entity7 suffered side - effects
among *reactions* were nausea , nightmares and insomnia in
@entity100 is advising against prescribing @entity7 to youngsters aged 10 to 19

@entity22:Data
@entity2:CNN
@entity1:London
@entity0:England
@entity7:Tamiflu
@entity4:UK
@entity54:Mexico
@entity18:HPA
@entity100:Japan
@entity115:Roche
@entity40:Eurosurveillance
@entity129:FDA
@entity96:Relenza
@entity94:European Union
@entity130:US
@entity91:Department of Health